2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percentage of surgical pathology reports for primary colorectal, endometrial,Continue reading “2024 MIPS Measure #491: Mismatch Repair (MMR) or Microsatellite Instability (MSI) Biomarker Testing Status in Colorectal Carcinoma, Endometrial, Gastroesophageal, or Small Bowel Carcinoma”
MIPS/CQM Archive
2024 MIPS Measure #493: Adult Immunization Status
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients 19 years of age and older who are up-to-dateContinue reading “2024 MIPS Measure #493: Adult Immunization Status”
2024 MIPS Measure #495: Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Patient-Reported Outcome-Based Performance Measure (PRO-PM) – High Priority Description The percentage of top-box responsesContinue reading “2024 MIPS Measure #495: Ambulatory Palliative Care Patients’ Experience of Feeling Heard and Understood”
2024 MIPS Measure #496: Cardiovascular Disease (CVD) Risk Assessment Measure – Proportion of Pregnant/Postpartum Patients that Receive CVD Risk Assessment with a Standardized Instrument
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of pregnant or postpartum patients who received a cardiovascular disease (CVD)Continue reading “2024 MIPS Measure #496: Cardiovascular Disease (CVD) Risk Assessment Measure – Proportion of Pregnant/Postpartum Patients that Receive CVD Risk Assessment with a Standardized Instrument”
2024 MIPS Measure #497: Preventive Care and Wellness (Composite)
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients who received age- and sex-appropriate preventive screenings and wellnessContinue reading “2024 MIPS Measure #497: Preventive Care and Wellness (Composite)”
2024 MIPS Measure #498: Connection to Community Service Provider
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process – High Priority Description Percent of patients 18 years or older who screenContinue reading “2024 MIPS Measure #498: Connection to Community Service Provider”
2024 MIPS Measure #499: Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients who had an intravitreal or periocular corticosteroid injection (e.g.,Continue reading “2024 MIPS Measure #499: Appropriate Screening and Plan of Care for Elevated Intraocular Pressure Following Intravitreal or Periocular Steroid Therapy”
2024 MIPS Measure #500: Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD)Continue reading “2024 MIPS Measure #500: Acute Posterior Vitreous Detachment Appropriate Examination and Follow-up”
2024 MIPS Measure #501: Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Process Description Percentage of patients with a diagnosis of acute posterior vitreous detachment (PVD)Continue reading “2024 MIPS Measure #501: Acute Posterior Vitreous Detachment and Acute Vitreous Hemorrhage Appropriate Examination and Follow-up”
2024 MIPS Measure #502: Improvement or Maintenance of Functioning for Individuals with a Mental and/or Substance Use Disorder
2024 COLLECTION TYPE: MIPS Clinical Quality Measures (CQMS) MEASURE TYPE: Outcome-Based Performance Measure (PRO-PM) – High Priority Description The percentage of patients aged 18Continue reading “2024 MIPS Measure #502: Improvement or Maintenance of Functioning for Individuals with a Mental and/or Substance Use Disorder”